Larotaxel
Larotaxel: An Experimental Taxane Drug[edit | edit source]
Larotaxel (also known by its code names XRP9881 and RPR109881) is a chemotherapeutic agent that belongs to the taxane class of drugs. Derived and refined for potential antineoplastic applications, Larotaxel showcases the characteristic mechanisms and properties inherent to taxanes, with a unique chemical profile distinguishing it from its contemporaries.
Taxane Class Overview[edit | edit source]
Taxanes are a class of diterpenes originally isolated from the bark of the Pacific yew tree, Taxus brevifolia. Their chemotherapeutic properties are primarily based on their ability to:
- Stabilize microtubule polymers.
- Prevent depolymerization, hindering cell division and proliferation[1].
Prominent members of the taxane class include:
- Paclitaxel (Taxol): The pioneering taxane drug with significant clinical efficacy[2].
- Docetaxel (Taxotere): A semi-synthetic analogue of paclitaxel with an improved efficacy-toxicity ratio in certain cancers[3].
Larotaxel: Distinct Features[edit | edit source]
Distinct from paclitaxel and docetaxel, Larotaxel boasts a specific chemical structure that may result in a unique pharmacodynamic and pharmacokinetic profile. However, as with many experimental drugs, extensive research is pivotal to elucidate the spectrum of its antitumor activities and potential side effects[4].
Clinical Evaluation & Applications[edit | edit source]
Larotaxel has been subjected to experimental evaluations for its:
- Mechanism of action in cell lines.
- Efficacy in various tumor models.
- Safety and tolerability in early-phase clinical trials.
Though its precise position in oncological therapeutics has not been fully established, preliminary investigations suggest potential utility in a spectrum of malignancies resistant to other taxane therapies[5].
Conclusion[edit | edit source]
Larotaxel encapsulates the ongoing efforts of researchers to optimize the therapeutic potential of taxanes, aiming to overcome the limitations of the first-generation agents. While it remains under investigation, Larotaxel's unique profile underscores the dynamic and evolving landscape of oncology drug development.
References[edit | edit source]
- ↑ Horwitz, S.B. (1994). Mechanism of action of taxol. Trends in Pharmacological Sciences, 15(5), 134-136.
- ↑ Rowinsky, E.K., et al. (1990). Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. Journal of Clinical Oncology, 8(12), 2010-2025.
- ↑ Tannock, I.F., et al. (2004). Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. New England Journal of Medicine, 351(15), 1502-1512.
- ↑ Bissery, M.C., et al. (1995). Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Research, 55(11), 2325-2333.
- ↑ Vrignaud, P., et al. (1998). Preclinical profile of XRP9881 (RPR 109881A), a novel taxane, and its activity in taxane-resistant cell lines. Anti-Cancer Drugs, 9(9), 759-771.
| Larotaxel Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
